Design and results of PERSIST-1 trial of pacritinib for myelofibrosis by Ruben Mesa
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Diffuse Large B-Cell Lymphoma
View expert index
View all diseases
View all trials
View all medicines
EMMA Vienna 2017
View upcoming conferences
View previous conferences
Chronic Lymphocytic Leukemia
The success story of indolent disease treatment expanded to difficult-to-treat patient groups
Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, from the Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses difficult to…
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
Elias Campo, MD, PhD, from the University of Barcelona, Hospital Clinic, Barcelona, Spain, discusses clonal evolution in chronic lymphocytic leukemia…
Diagnosis and Initial Treatment of CLL
Peter Hillmen, MD, PhD from the University of Leeds, Leeds, UK is joined by Richard Furman, MD, Weill Cornell Medical…
The Progression and Evolution of CLL: Mechanisms and Therapies
Nicole Lamanna, MD, from Columbia University Medical Centre, New York, NY, provides an overview from the session on ‘Progression/Evolution of…
Overcoming the challenges of evolving standards of care in CLL: advice for community physicians
Nicole Lamanna, MD from Columbia University Medical Centre, New York, NY discusses the benefits of using mutational analysis in the…
How can doctors discuss CLL treatment options with patients?
Clemens Wendtner, MD from the University of Cologne, Cologne, Germany, advises doctors on how to discuss different treatment options with…
What’s next for Richter’s syndrome?
Barbara Eichhorst, MD, from the University of Cologne, Cologne, Germany, discusses the challenges of treating Richter’s syndrome at the 2017…
What are the benefits of having different chronic lymphocytic leukemia (CLL) treatment options?
Barbara Eichhorst, MD, from the University of Cologne, Cologne, Germany, discusses the advantages of having many treatment options in chronic…
What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
Clemens Wendtner, MD from the University of Cologne, Cologne, Germany, discusses genetic risk factors for chronic lymphocytic leukemia (CLL) at…
How can genetic analysis be used to determine chronic lymphocytic leukemia (CLL) treatment?
Barbara Eichhorst, MD, from the University of Cologne, Cologne, Germany, discusses implications of genetic testing in chronic lymphocytic leukemia (CLL)…
Sign up for the latest news and videos
Is CLL curable today?
How far are we from a cure for CLL?
Mechanism of action of venetoclax (ABT-199) and its side effects
Myeloma 2016: Panel discussion on novel treatments
Highlights from the International Workshop of the German CLL Study Group